In this webinar, Ergomed’s experts share their insights on how they have adapted and are continuing to provide reliable and uninterrupted services for their clients, keeping the patient’s safety and well-being as the central focus   Topics include: Ensuring the oversight of ongoing trials in line with regulatory guidance Starting up new trials during the […]

In this webinar, Ergomed’s experts share their insights on how they have adapted and are continuing to provide reliable and uninterrupted services for their clients, keeping the patient’s safety and well-being as the central focus

 

Topics include:

  • Ensuring the oversight of ongoing trials in line with regulatory guidance
  • Starting up new trials during the pandemic
  • Practical and logistical issues and mitigations

 

Presenters: 

  • Alex Artyomenko MD, Head of Rare Disease and RWE Research
  • Christa van Kan, Strategic Director Rare Diseases
  • Sally Amanuel MBA, Head of Regulatory and Clinical Delivery

 

Please click HERE to see the webinar.

This site uses cookies to personalize and customize your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.


  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services
Secured By miniOrange